Clinical study
Radiation heart disease: Analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart

https://doi.org/10.1016/0002-9343(81)90574-XGet rights and content

Abstract

Certain clinical and necropsy findings are described in 16 young (aged 15 to 33 years) patients who received > 3,500 rads to the heart five to 144 months before death. All 16 had some radiation-induced damage to the heart: 15 had thickened pericardia (five of whom had evidence of cardiac tamponade); eight had increased interstitial myocardial fibrosis, particularly in the right ventricle; 12 had fibrous thickening of the mural endocardium and 13 of the valvular endocardium. Except for valvular thickening, the changes were more frequent in the right side of the heart than in the left, presumably because of higher radiation doses to the anterior surface of the heart. In six of the 16 study patients and in one of 10 control subjects, one or more major epicardial coronary arteries were narrowed from 76 to 100 percent in cross-sectional area by atherosclerotic plaque; one patient had a healed myocardial infarct at necropsy and one died suddenly. In 10 patients and in the 10 control subjects, the four major epicardial coronary arteries were examined quantitatively: 6 percent of the 469 five millimeter segments of coronary artery from the patients were narrowed from 76 to 100 percent (controls = 0.2 percent, p = 0.06) and 22 percent were narrowed from 51 to 75 percent (controls = 12 percent). The proximal portion of the arteries in the patients had significantly more narrowing than the distal portions. The arterial plaques in the patients were largely composed of fibrous tissue; the media were frequently replaced by fibrous tissue, and the adventitia were often densely thickened by fibrous tissue. In five patients, there was focal thickening (with or without luminal narrowing) of the intramural coronary arteries. Thus, radiation to the heart may produce a wide spectrum of functional and anatomic changes but particularly damage to the pericardia and the underlying epicardial coronary arteries.

References (47)

  • H Huff et al.

    Coronary-artery occlusion after radiation

    N Engl J Med

    (1972)
  • DL Rodgers

    Precocious myocardial infarction after radiation treatment for Hodgkin's disease

    Chest

    (1976)
  • SM Iqbal et al.

    Bypass graft for coronary artery stenosis following radiation therapy

    Chest

    (1977)
  • FW Hartman et al.

    Heart lesions produced by deep x-rays. An experimental and clinical study

    Bull Johns Hopkins Hosp

    (1927)
  • AU Desjardins

    Action of roentgen rays and radium on the heart and lungs

    Am J Roentgenol

    (1932)
    AU Desjardins

    Action of roentgen rays and radium on the heart and lungs

    Am J Roentgenol

    (1932)
    AU Desjardins

    Action of roentgen rays and radium on the heart and lungs

    Am J Roentgenol

    (1932)
  • JE Leach

    Effect of roentgen therapy on the heart; clinical study

    Arch Int Med

    (1943)
  • JR Fried et al.

    Post-irradiation changes in the lungs and thorax. A clinical, roentgenological and pathological study, with emphasis on late and terminal stages

    Am J Roentgenol

    (1940)
  • H Blumenfeld et al.

    Chronic massive pericardial effusion following roentgen therapy for carcinoma of the breast

    Radiology

    (1945)
  • R Tricot et al.

    La péricardite constrictive post-radiotherapique (à propos d'un cas personnel)

    Arch Mal Coeur

    (1954)
  • TMD Gimlette

    Constrictive pericarditis

    Br Heart J

    (1959)
  • DW Hurst

    Radiation fibrosis of pericardium with cardiac tamponade

    Can Med Assoc J

    (1959)
  • DC Connolly et al.

    Pericarditis: a 10 year survey

    Am J Cardiol

    (1961)
  • I Steinberg

    Effusive-constrictive radiation pericarditis. Two cases illustrating value of angiocardiography in diagnosis

    Am J Cardiol

    (1967)
  • Cited by (422)

    • Radiation therapy cardiovascular risks

      2022, Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease
    • Vascular disease prevention: Before cancer therapy

      2022, Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease
    • Vascular disease during cancer therapy

      2022, Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease
    • Cardiac complications of cancer therapies

      2022, Advances in Cancer Research
      Citation Excerpt :

      The resulting inflammatory process drives an increase in myocardial cell death, which fosters the accumulation of reparative fibrous tissue with consequent ventricular stiffening and impaired elasticity and cardiac compliance (Taunk et al., 2015). Valvulopathy has been reported following RT, with more than 80% of patients who receive at least 35 Gy experiencing direct damage of the valve, including thickening, increased calcification, and leaflet fibrosis (Brosius, Waller, & Roberts, 1981; Taunk et al., 2015). Increased evidence of pericardial disease was experienced by almost 90% of the patients exposed to significant mediastinal radiation (Groarke et al., 2014).

    • Imaging of the Chest After Radiotherapy and Potential Pitfalls

      2021, Seminars in Ultrasound, CT and MRI
      Citation Excerpt :

      In addition to MRI's advantage of not using ionizing radiation and accurately showing a thickened pericardium27, MRI also shows septal flattening and diastolic bouncing characteristic of constrictive pericarditis, best seen in the 4-chamber cine steady-state free precession MR images, helpful in differentiating constrictive pericarditis from restrictive cardiomyopathy. RT can cause cardiomyopathy due to direct injury and myocardial fibrosis or ischemia.28 Radiation induced myocardial fibrosis can result in a broad spectrum of myocardial dysfunction most commonly resulting in restrictive cardiomyopathy.

    View all citing articles on Scopus

    Present address: Department of Medicine, University of Michigan Medical Center, Ann Arbor, MI 48104.

    1

    From the Pathology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

    View full text